Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Cousineau

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Immunology|March 14, 2024
Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killingMichel Demeule, Jean-Christophe Currie, Cyndia Charfi, et al.
Frontiers in Immunology|March 14, 2024
Corrigendum: Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killingMichel Demeule, Jean-Christophe Currie, Cyndia Charfi, et al.
Cell Reports. Medicine|September 20, 2023
Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinomaBertrand Allard, Célia Jacoberger-Foissac, Isabelle Cousineau, et al.
Journal for Immunotherapy of Cancer|March 27, 2021
High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancerYacine Bareche, Sandra Pommey, Mayra Carneiro, et al.
Oncoimmunology|May 5, 2020
Prognostic value of CD73 expression in resected colorectal cancer liver metastasisNouredin Messaoudi, Isabelle Cousineau, Elizabeth Arslanian, et al.
Cancer Research|September 13, 2015
CD73 is associated with poor prognosis in high-grade serous ovarian cancerMartin Turcotte, Kathleen Spring, Sandra Pommey, et al.
British Journal of Cancer|January 4, 2022
Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patternsNouredin Messaoudi, David Henault, David Stephen, et al.
Cancer Immunology Research|November 21, 2022
CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic CancerCélia Jacoberger-Foissac, Isabelle Cousineau, Yacine Bareche, et al.
Cancer Discovery|June 20, 2022
IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular CarcinomaTuran Aghayev, Aleksandra M Mazitova, Jennifer R Fang, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Immunology|March 14, 2024
Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killingMichel Demeule, Jean-Christophe Currie, Cyndia Charfi, et al.
Frontiers in Immunology|March 14, 2024
Corrigendum: Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killingMichel Demeule, Jean-Christophe Currie, Cyndia Charfi, et al.
Cell Reports. Medicine|September 20, 2023
Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinomaBertrand Allard, Célia Jacoberger-Foissac, Isabelle Cousineau, et al.
Journal for Immunotherapy of Cancer|March 27, 2021
High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancerYacine Bareche, Sandra Pommey, Mayra Carneiro, et al.
Oncoimmunology|May 5, 2020
Prognostic value of CD73 expression in resected colorectal cancer liver metastasisNouredin Messaoudi, Isabelle Cousineau, Elizabeth Arslanian, et al.
Cancer Research|September 13, 2015
CD73 is associated with poor prognosis in high-grade serous ovarian cancerMartin Turcotte, Kathleen Spring, Sandra Pommey, et al.
British Journal of Cancer|January 4, 2022
Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patternsNouredin Messaoudi, David Henault, David Stephen, et al.
Cancer Immunology Research|November 21, 2022
CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic CancerCélia Jacoberger-Foissac, Isabelle Cousineau, Yacine Bareche, et al.
Cancer Discovery|June 20, 2022
IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular CarcinomaTuran Aghayev, Aleksandra M Mazitova, Jennifer R Fang, et al.
Pageof 2